IGC Pharma
25 hedge funds and large institutions have $5.08M invested in IGC Pharma in 2020 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.51% more ownership
Funds ownership: 5.1% → 7.62% (+2.5%)
22% less call options, than puts
Call options by funds: $377K | Put options by funds: $485K
Holders
25
Holding in Top 10
–
Calls
$377K
Puts
$485K
Top Buyers
| 1 | +$1.37M | |
| 2 | +$380K | |
| 3 | +$200K | |
| 4 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
+$44K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$40K |
Top Sellers
| 1 | -$115K | |
| 2 | -$109K | |
| 3 | -$33.5K | |
| 4 |
PIA
Powell Investment Advisors
Miami,
Florida
|
-$26K |
| 5 |
Morgan Stanley
New York
|
-$4.33K |